Natalizumab extended-interval dosing in a real-life setting. Jeantin L, Boudot de la Motte M, Deschamps R, Gueguen A, et al. J Neurol Sci 2023;450:120689.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jeantin L, Boudot de la Motte M, Deschamps R, Gueguen A, et al. Natalizumab extended-interval dosing in a real-life setting. J Neurol Sci 2023;450:120689.
PMID: 37210938